Τόμος 27 (2009) – Τεύχος 3 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 27 (2009) – Issue 3– Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Μαρία Μυρωνίδου-Τζουβελέκη, Ιωάννης Αργύρης

Α΄ Εργαστήριο Φαρμακολογίας, Ιατρική Σχολή, Αριστοτέλειο Πανεπιστήμιο, Θεσσαλονίκη, Ελλάς

Maria Mironidou-Tzouveleki, Ioannis Αrgyris

A΄ Laboratory of Pharmacology, Medical School, Aristotle University, Thessaloniki, Hellas

2. Hartmann T.J., Kopp H.-G.: Bone sarcomas. Update Cancer Therapeutics 1: 65-74 (2006).

3. Skinner B.H.: Current Diagnosis & Treatment in Orthopedics. Lange Medical Books/McGraw-Hill, N. York, 2006

4. Cotran R., Kumar V., Collins T. (eds): Robbins Pathologic Basis of Disease. WB Saunders Company, Philadelphia, 1999

5. Desandes E.: Survival from adolescent cancer. Cancer Treat. Rev. 33: 609-615 (2007)

6. Longhi A., Setola E., Versari M., et al.: The role of chemotherapy in the treatment of bone and soft tissue sarcomas. Curr. Orthop. 19: 119-126 (2005).

7. Van den Berk H.: Biology and treatment of malignant solid tumors in childhood. Update Cancer Therapeutics 2: 177-191 (2007)

8. Udayakumar A.M., Sundareshan T.S., Goud Mallana T., et al.: Cytogenetic characterization of Ewing tumors using fine needle aspiration samples: a 10-year experience and review of the literature. Cancer Genetics Cytogenetics 127: 42-48 (2001)

9. Αurias A., Rimbaut C., Buffe D., et al.: Chromosomal translocations in Ewing Sarcoma. N. Engl. J. Med. 309: 496-498 (1983)

10. Taylor M., Guillon M., Champion V., et al.: La tumeur d’Ewing. Archives de pédiatrie 12: 1383-1391 (2005)

11. Abdul-Karim F.W., Bauer T.W., Kilpatrick S.E., et al.: Recommendations for the reporting of bone tumors. Hum. Pathol. 35: 1173-1178 (2004).

12. Milano G.M., Cozza R., Ilari I., et al.: High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors – the Bambino Gesù children’s hospital experience. Cancer 106: 1838-45 (2006).

13. Obata H., Ueda T., Kawai A., et al.: Clinical outcome of patients with Ewing sarcoma family of tumors of bone in Japan – the Japanese Musculoskelatal Group Cooperative Study. Cancer 109: 767-75 (2007)

14. Harvey RA, Champe PC: Φαρμακολογία (3η έκδοση). Επιστημονικές Εκδόσεις Παρισιάνου, Αθήνα (2007)

15. Rang H.P., Dale M.M., Ritter J.M., Moore P.K.: Φαρμακολογία. Εκδόσεις Παρισιάνου, Αθήνα, 2007

16. Εθνικό Συνταγολόγιο(ΕΟΦ). Εκδόσεις ΕΟΦ, Αθήνα 2007

17. Brunton L., Lazo J., Parker K.: Goodman & Gillman’s The Pharmacological Basis of Therapeutics. McGraw-Hill, N. York, 2005

18. Katzung B.: Basic & Clinical Pharmacology. Lange Medical Books/McGraw-Hill, New York, 2004

19. Juergens C., Weston C., Lewis I., et al.: Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G 99 clinical trial. Pediatr. Blood Cancer 47: 22-29 (2006)

20. Bacci G., Mercuri M., Longhi A., et al.: Neoadjuvant chemotherapy for Ewing’s tumour of bone: recent experience at the Rizzoli Orthopaedic Institute. Eur. J. Cancer 38: 2243-2251 (2002)

21. Estlin EJ and Veal GJ: Clinical and cellular pharmacology in relation to solid tumours of childhood. Cancer Treat. Rev. 29: 253-273 (2003).

22. Pinkerton C.R., Battaillard A., Guillo S., et al.: Treatment strategies for metastatic Ewing’s sarcoma. Eur. J. Cancer 37: 1338-1344 (2001).

23. Hunold A., Weddeling N., Paulussen M., Ranft A., Liebscher C., Jürgens H.: Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors. Pediatr. Blood Cancer 47: 795-800 (2006)

24. Wunder J.S., O’Nielsen T., Maki G.R., O’Sullvan B., Alman B.A.: Opportunities for improving the therapeutic ratio for patients with sarcoma. Lancet Oncology 8: 513-524 (2007)

25. Tsartsalis S., Mironidou-Tzouveleki M.: New challenges in nanotechnology: the use of dendrimers in drug administration. Aristotle Univ. Med. J. 36(2): 47-52 (2009)

26. Kovar H., Ban J., Popisilova S.: Potentials for RNAi in sarcoma research and therapy: Ewing’s sarcoma as a model. Semin. Cancer Biol. 13: 273-281 (2003)

27. O. Lewis V.: What’s new in musculoskeletal oncology. J. Bone Joint Surg. Am. 89: 1399-1407 (2007)